| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.48T | 12.96T | 13.02T | 10.97T | 9.92T |
| Gross Profit | 3.84T | 3.66T | 3.33T | 3.24T | 2.70T |
| EBITDA | 2.73T | 2.67T | 2.45T | 2.31T | 1.97T |
| Net Income | -326.87B | 1.14T | 970.57B | 1.01T | 882.18B |
Balance Sheet | |||||
| Total Assets | 15.68T | 35.29T | 34.11T | 31.15T | 29.65T |
| Cash, Cash Equivalents and Short-Term Investments | 2.21T | 3.45T | 2.33T | 1.83T | 2.47T |
| Total Debt | 1.67T | 4.20T | 4.09T | 4.06T | 3.57T |
| Total Liabilities | 7.17T | 26.78T | 26.35T | 24.50T | 23.95T |
| Stockholders Equity | 8.12T | 8.18T | 7.59T | 6.60T | 5.65T |
Cash Flow | |||||
| Free Cash Flow | 1.49T | 1.67T | 749.27B | -298.94B | 792.55B |
| Operating Cash Flow | 1.95T | 2.32T | 1.37T | 314.69B | 1.23T |
| Investing Cash Flow | -1.95T | -930.12B | -818.89B | -1.05T | -728.78B |
| Financing Cash Flow | -861.20B | -298.24B | -210.71B | 84.30B | -336.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥4.41T | 32.60 | 1.37% | 2.29% | 2.77% | 500.36% | |
73 Outperform | ¥392.02B | 21.74 | 5.53% | 3.55% | 5.54% | 128.65% | |
66 Neutral | ¥167.68B | 9.71 | 13.53% | 1.34% | -3.63% | -14.77% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥8.33T | 44.23 | 4.25% | 1.99% | -4.84% | -48.25% | |
53 Neutral | ¥21.54T | -64.19 | 14.45% | 0.55% | -3.68% | -129.40% | |
48 Neutral | ¥396.11B | 8.52 | ― | ― | -12.38% | 31.41% |